Xiuzhi Zheng
Biographic Data
| ID | 3912921 |
|---|---|
| NAME | Xiuzhi Zheng |
| GIVEN NAMES | Xiuzhi |
| FAMILY NAME | Zheng |
| SIGNATURE | ZHENG X |
| AFFILIATIONS | Fujian Medical University |
| ORCID | 0000-0002-6633-9811 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and Mapk axis in Alzheimer's disease
Our results suggest that SSc treatment ameliorates cognitive deficits and related tau pathological features in the hTau AD mouse model. The antioxidant effects of SSc might be responsible for the therapeutic potential of SSc in protecting against tau pathology and cognitive decline
Enterprise ESG Performance, Digital Transformation, and Firm Performance
Enterprise environmental, social, and governance (ESG) performance and digital transformation are of great value for enhancing firm performance. Based on data from A-share listed companies in China from 2016 to 2022, a regression model was constructed to verify the influence of ESG performance on company performance under digital transformation. Research suggests that ESG performance enhances firm performance and that enterprise innovation has an…
No prominent works on this page.
Enterprise ESG Performance, Digital Transformation, and Firm Performance
Enterprise environmental, social, and governance (ESG) performance and digital transformation are of great value for enhancing firm performance. Based on data from A-share listed companies in China from 2016 to 2022, a regression model was constructed to verify the influence of ESG performance on company performance under digital transformation. Research suggests that ESG performance enhances firm performance and that enterprise innovation has an…
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and Mapk axis in Alzheimer's disease
Our results suggest that SSc treatment ameliorates cognitive deficits and related tau pathological features in the hTau AD mouse model. The antioxidant effects of SSc might be responsible for the therapeutic potential of SSc in protecting against tau pathology and cognitive decline
Alzheimer's disease (1 works) · Alzheimer's disease research and treatments (1 works) · Biology (1 works) · Business (1 works) · Cell Biology (1 works) · China (1 works) · Computer Science (1 works) · Digital transformation (1 works) · Disease (1 works) · Energy, Environment, Economic Growth (1 works)